958 related articles for article (PubMed ID: 29514017)
61. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
[TBL] [Abstract][Full Text] [Related]
62. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
[TBL] [Abstract][Full Text] [Related]
63. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
[TBL] [Abstract][Full Text] [Related]
64. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
65. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
66. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
67. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
[TBL] [Abstract][Full Text] [Related]
68. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Ryu KH; Kim SH; Yoon JH; Lee Y; Paik JH; Lim YJ; Lee KH
Acta Radiol; 2016 Feb; 57(2):133-41. PubMed ID: 25638800
[TBL] [Abstract][Full Text] [Related]
69. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
[TBL] [Abstract][Full Text] [Related]
70. Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study.
Horvat N; Veeraraghavan H; Nahas CSR; Bates DDB; Ferreira FR; Zheng J; Capanu M; Fuqua JL; Fernandes MC; Sosa RE; Jayaprakasam VS; Cerri GG; Nahas SC; Petkovska I
Abdom Radiol (NY); 2022 Aug; 47(8):2770-2782. PubMed ID: 35710951
[TBL] [Abstract][Full Text] [Related]
71. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
72. A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer.
Cusumano D; Meijer G; Lenkowicz J; Chiloiro G; Boldrini L; Masciocchi C; Dinapoli N; Gatta R; Casà C; Damiani A; Barbaro B; Gambacorta MA; Azario L; De Spirito M; Intven M; Valentini V
Radiol Med; 2021 Mar; 126(3):421-429. PubMed ID: 32833198
[TBL] [Abstract][Full Text] [Related]
73. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
[TBL] [Abstract][Full Text] [Related]
74. Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
Tibermacine H; Rouanet P; Sbarra M; Forghani R; Reinhold C; Nougaret S;
Br J Surg; 2021 Oct; 108(10):1243-1250. PubMed ID: 34423347
[TBL] [Abstract][Full Text] [Related]
75. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
[TBL] [Abstract][Full Text] [Related]
76. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
Engin G; Sharifov R; Güral Z; Sağam EK; Sağlam S; Balik E; Asoğu O; Yamaner S; Güllüoğu M; Kapran Y; Özel S
Diagn Interv Radiol; 2012; 18(6):574-81. PubMed ID: 22798154
[TBL] [Abstract][Full Text] [Related]
77. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer.
Yuan Y; Pu H; Chen GW; Chen XL; Liu YS; Liu H; Wang K; Li H
Eur Radiol; 2021 Jan; 31(1):200-211. PubMed ID: 32740816
[TBL] [Abstract][Full Text] [Related]
78. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
79. Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer.
Paiar F; Gabelloni M; Pasqualetti F; Cocuzza P; Montrone S; Arena C; Faggioni L; Falaschi Z; Del Secco L; Alberich-Bayarri A; Bonmati LM; Neri E
Anticancer Res; 2023 Feb; 43(2):781-788. PubMed ID: 36697103
[TBL] [Abstract][Full Text] [Related]
80. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence.
Fütterer JJ; Yakar D; Strijk SP; Barentsz JO
Eur J Radiol; 2008 Jan; 65(1):66-71. PubMed ID: 18164156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
